🔗 Share this article

This year's Nobel Prize in medical science has been awarded for transformative findings that clarify how the body's defense network targets dangerous pathogens while protecting the body's own cells.

A trio of renowned scientists—Japan's Prof. Sakaguchi and US scientists Mary Brunkow and Dr. Ramsdell—share this accolade.

The research identified specialized "security guards" within the immune system that eliminate rogue defense cells that could attacking the organism.

The discoveries are now paving the way for innovative treatments for autoimmune diseases and malignancies.

These laureates will divide a prize fund valued at 11m SEK.

Decisive Findings

"Their research has been decisive for understanding how the immune system functions and why we don't all suffer from severe self-attack conditions," commented the chair of the Nobel Committee.

The team's studies address a core question: In what way does the immune system protect us from numerous invaders while keeping our own tissues unharmed?

The immune system employs immune cells that search for signs of disease, even pathogens and bacteria it has not met before.

These cells utilize sensors—called recognition units—that are generated randomly in a vast number of combinations.

This gives the defense network the capacity to fight a wide array of invaders, but the unpredictability of the mechanism inevitably creates white blood cells that may target the host.

Protectors of the Immune System

Researchers earlier understood that some of these problematic white blood cells were destroyed in the immune organ—where white blood cells mature.

This year's Nobel Prize recognizes the discovery of T-reg cells—known as the body's "peacekeepers"—which travel through the system to neutralize any defenders that attack the body's own tissues.

We know that this process fails in autoimmune diseases such as type-1 diabetes, MS, and RA.

A prize committee stated, "These discoveries have established a new field of investigation and accelerated the development of new treatments, for instance for tumors and autoimmune diseases."

Regarding malignancies, regulatory T-cells prevent the system from attacking the tumor, so research are focused on reducing their numbers.

For autoimmune diseases, trials are testing boosting T-reg cells so the body is not being harmed. A comparable method could also be useful in reducing the chances of transplanted organ failure.

Innovative Experiments

Prof Sakaguchi, of a Japanese institution, performed experiments on mice that had their immune gland extracted, causing self-attack conditions.

He demonstrated that introducing defense cells from other mice could prevent the illness—suggesting there was a mechanism for blocking immune cells from harming the body.

Mary Brunkow, affiliated with the Institute for Systems Biology in Seattle, and Fred Ramsdell, currently at a biotech firm in San Francisco, were studying an genetic autoimmune disease in rodents and humans that led to the discovery of a genetic factor vital for the way T-regs function.

"The groundbreaking work has uncovered how the immune system is kept in check by regulatory T cells, stopping it from mistakenly attacking the body's own tissues," commented a leading physiology specialist.

"This work is a remarkable example of how basic physiological research can have broad implications for public health."